🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07808021
Starting soon Not applicable

Comparative Effects of Acceptance and Commitment Therapy, Cognitive Behavioral Therapy, and Treatment-as-Usual on Depression Among People With Marital Crisis

NCT07808021 · tracked via the Priya Life Science China tracker
Sponsor
Universiti Sains Malaysia
Phase
Not applicable
Started
2027-01-01
Last updated
2026-09-08

Condition(s) studied

Depression - Major Depressive DisorderAnxietyMarital Conflict

Investigational drug(s) / intervention(s)

Acceptance and Commitment TherapyCognitive Behavioral Therapy

Acceptance and Commitment Therapy: ACT combined with a single antidepressant. Participants randomized to the ACT arm receive an eight-week manualized group ACT program, with weekly 90-minute sessions delivered in closed groups of approximately 8 to 10 participants per group. The program is conducted in adherence to the ACT protocol developed by Hayes et al. (2012), targeting the six core processes of psychological flexibility, namely acceptance, cognitive defusion, present-moment awareness, self-as-context, values clarification, and committed action. To consider the program successfully completed, each participant is expected to attend at least 6 of the 8 sessions, with a maximum allowable late arrival of 10 minutes per session.

Cognitive Behavioral Therapy: CBT combined with a single antidepressant. Participants randomized to the CBT arm receive an eight-week manualized group CBT program, with weekly 90-minute sessions delivered in closed groups of approximately 8 to 10 participants per group, conducted in adherence to established cognitive behavioural therapy for depression adapted for delivery in a group format (Bieling et al., 2022). The CBT manual used in this trial is based on the validated cognitive therapy protocol for depression established by Beck, Rush, Shaw, and Emery (1979), comprising cognitive restructuring and behavioural activation, which remains the standard manualized protocol for cognitive therapy of depression and has been extensively validated in randomized controlled trials. To consider the program successfully completed, each participant is expected to attend at least 6 of the 8 sessions, with a maximum allowable late arrival of 10 minutes per session.

Study summary

This parallel three-arm, single-blind (assessor-blinded), randomized controlled trial (RCT) aims to compare the effects of ACT, CBT, and treatment-as-usual (TAU) on the severity of depressive symptoms (primary outcome), the severity of comorbid anxiety symptoms, marital satisfaction, intimacy with spouse, quality of life, and experiential avoidance (secondary outcomes) among people diagnosed with major depressive disorder (MDD) with marital crisis across four time points (T0 = baseline (pre-intervention), T1 = post-intervention (immediately after completion of the intervention, 8 weeks after its commencement), T2 = follow-up at 12 weeks after completion of the intervention, T3 = follow-up at 24 weeks after completion of the intervention).

A total of 120 MDD patients with marital crisis will be recruited from two study sites and randomized by stratified block randomization into three groups (ACT, CBT and TAU) in a 1:1:1 ratio. ACT group therapy will be conducted once a week for 8 weeks in the ACT group, while CBT group therapy once a week for 8 weeks will be carried out in the CBT group. During baseline assessment (T0), the demographic and clinical characteristics, the Chinese versions of the Beck Depression Inventory-II (BDI-II), the Generalized Anxiety Disorder 7-item scale (GAD-7), the Personal Assessment of Intimacy in Relationships (PAIR), the Dyadic Adjustment Scale (DAS), the World Health Organization Quality of Life-BREF (WHOQOL-BREF), and the Acceptance and Action Questionnaire-II (AAQ-II) will be administered to all participants. The re-administration of the BDI-II, GAD-7, PAIR, DAS, WHOQOL-BREF and AAQ-II will be carried out at T1, T2, and T3.

Eligibility

Sex
ALL
Min age
20 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: 1. Meets DSM-5-TR diagnostic criteria for major depressive disorder, confirmed by the Mini International Neuropsychiatric Interview (MINI) structured clinical interview (American Psychiatric Association, 2022). 2. Beck Depression Inventory-II (BDI-II) total score of 20 or above, indicating moderate to severe depressive symptoms (Beck et al., 1996). 3. Dyadic Adjustment Scale (DAS) total score of 97 or below, operationally defining marital crisis (Spanier, 1976). 4. Age between 20 and 60 years. 5. Currently taking a single antidepressant medication for a minimum of two weeks. Rather than being required to remain on an unchanged dose, participants agree to have their antidepressant regimen managed by their treating psychiatrist according to clinical need for the duration of the study; any change in medication or dose is documented and included as a time-varying covariate in the analysis. Exclusion Criteria: 1. Current diagnosis of symptomatic bipolar mood disorder or psychotic disorder which would interfere with their ability to answer questionnaires and participate in the study. 2. History of substance abuse or acute alcohol use disorder. 3. Prior receipt of any structured psychotherapy before study enrollment. 4. Severe physical illness or cognitive impairment that would prevent meaningful participation in group therapy sessions or completion of assessment instruments. 5. Current exposure to active intimate partner violence or domestic abuse. This is screened at the face-to-face assessment using a brief standardized instrument, and it is applied to safeguard participant safety during the disclosure of marital distress in the group setting. Individuals who screen positive are not enrolled and are referred to appropriate local domestic-violence support services.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Yunfu City Yuncheng District People's Hospital Yunfu Guangdong

More Universiti Sains Malaysia trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07808021 on ClinicalTrials.gov ↗ ← All trials in China